Embecta - About the company
Embecta is a public company based in Parsippany (United States), founded in 2022. It operates as a Manufacturer of insulin delivery solutions, including pen needles and insulin syringes. The company has 65 active competitors, including 13 funded and 17 that have exited. Its top competitors include companies like Tandem Diabetes, Insulet and Ypsomed.
Company Details
Manufacturer of insulin delivery solutions, including pen needles and insulin syringes. The company provides solutions focused on improving the lives of people with diabetes. It develops and provides solutions that make life better for people with diabetes, advancing innovation in insulin delivery to improve the injection experience. The company also provides access to education and resources on proper injection technique.
- Website
- www.embecta.com
- Social
- Email ID
- *****@embecta.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2022
Location
Parsippany, United States
Stage
Public
Ranked
9th among 65 active competitors
Annual Revenue
$1B+ as on Sep 30, 2025
Employee Count
1,165 as on Aug 31, 2026
Investment & Acquisitions
Exit Details
Public
Legal entities associated with Embecta
Embecta is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
EMBECTA INDIA PRIVATE LIMITED CIN: U51909HR2021FTC115336 , India, Active | Nov 03, 2021 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 41 (As on Aug 01, 2025) | |
EMBECTA CORP. CIN: 1872789 , United States, Active | Jul 07, 2021 | $1B+ (As on Sep 30, 2025) | 2100 (As on Sep 30, 2024) | - |
Embecta's IPO details
Embecta got listed on Mar 22, 2022.
Click here to take a look at Embecta's IPO in detail
Sign up to download Embecta's company profile
Embecta's funding and investors
Embecta has not raised any funding rounds yet.
Embecta's founders and board of directors
Founder? Claim ProfileEmbecta's employee count trend
Embecta has 1,165 employees as of Aug 26. Here is Embecta's employee count trend over the years:
Uncover Embecta's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Embecta's Competitors and alternates
Top competitors of Embecta include Tandem Diabetes, Insulet and Ypsomed. Here is the list of Top 10 competitors of Embecta, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Tandem Diabetes 2008, San Diego (United States), Public | Developer of devices for continuous glucose monitoring and manual insulin delivery | $101M | 77/100 | |
2nd | Insulet 2000, Boston (United States), Public | Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | $120M | 74/100 | |
3rd |  Ypsomed 2003, Burgdorf (Switzerland), Acquired | Developer of self delivery injection systems and diabetes care systems | $7.45M | 64/100 | |
4th | Kaleido 2013, Utrecht (Netherlands), Series D | Developer of insulin therapy for treating diabetes | $183M | 63/100 | |
5th | CeQur 2008, Horw (Switzerland), Series E | Developer of wearable insulin delivery patch | $492M | 59/100 | |
6th | Microtech Medical 2011, Hangzhou (China), Public | Medical devices developer for diabetes care | $88.2M | 58/100 | |
7th | Sigrid Therapeutics 2014, Stockholm (Sweden), Series C | Developer of therapies to treat metabolic and chronic lifestyle diseases | $27M | 57/100 | |
8th |  Omnipod 1999, Acton (United States), Unfunded | Provider of smart wearable disposable pod provides insulin delivery | - | - | 54/100 |
9th |  Embecta 2022, Parsippany (United States), Public | Manufacturer of insulin delivery solutions, including pen needles and insulin syringes | - | - | 53/100 |
10th | Valeritas 2003, Bridgewater (United States), Acquired | Developer of wearable insulin patch pumps for insulin delivery through the skin | $231M | 52/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Embecta's competitors? Click here to see the top ones
Embecta's Investments and acquisitions
Embecta has acquired Owen Mumford. Embecta has not made any investments as of now.Reports related to Embecta
Here is the latest report on Embecta's sector:
News related to Embecta
Filter this listMedia has covered Embecta for a total of 28 events in the last 1 year, 4 of them have been about company updates and 4 about people movement.
•
LINC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lincoln Educational Services Corporation Investors with Losses Have Opportunity to Lead Class Action Lawsuit!Access Newswire•Sep 16, 2026•Lincoln, Bronstein, Gewirtz & Grossman, Embecta, Hagens Berman Sobol Shapiro and 2 others
•
•
•
•
Embecta Corp. Investor Alert: Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPR Newswire•Aug 13, 2026•Embecta, Bleichmar Fonti & Auld
•
•
Embecta Corp. Sued for Securities Law ViolationsPR Newswire•Aug 03, 2026•DJS Law Group, Embecta, Schall Law Firm, Kaplan Fox and 3 others
•
EMBC Shareholder Alert: Lead Plaintiff Deadline in Embecta Corp. Securities Class Action - August 17, 2026PR Newswire•Jul 16, 2026•Embecta, Kaplan Fox
•
Pomerantz LLP Calls Attention to Class Action Against Embecta Corp.Newswire•Jul 07, 2026•Pomerantz, Embecta, Bleichmar Fonti & Auld, DJS Law Group and 3 others
•
EMBC DEADLINE: Levi & Korsinsky Reminds Embecta Corp. Investors of Upcoming Securities Reflector•Jun 22, 2026•Embecta, Pomerantz
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Embecta
Explore our recently published companies
- Una Home Care - Beverly Hills based, 2026 founded, Unfunded company
- Boooply - 2026 founded, Unfunded company
- Uaity - 2026 founded, Unfunded company
